SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

79 hedge funds and large institutions have $464M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$941K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$27.9M
2 +$5.4M
3 +$3.67M
4
Two Sigma Investments
Two Sigma Investments
New York
+$2.63M
5
State Street
State Street
Massachusetts
+$2.05M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$90.8M
2
$70.6M
3
$50.4M
4
$38.9M
5
$35.4M
6
$31.3M
7
$20.3M
8
$16.4M
9
$15.9M
10
$9.01M
11
$8.46M
12
$7.36M
13
$6.01M
14
$6.01M
15
$5.32M
16
$5.25M
17
$5.22M
18
$4.26M
19
$2.91M
20
$2.67M
21
$2.63M
22
$2.48M
23
$2.26M
24
$2.17M
25
$1.94M